Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>DLBCL R/R*** > Treatment > USA. G. CD20xCD3 T-cell BiSpecific

---

Ab

USA. G. CD20xCD3 T-cell BiSpecific's subsections
(*) CA Approval Date: 2023. 03
(*) USA Approval Date: 2023. 06.15
Company
Generic Name
Patent>CA Patent Number
Patent>USA Patent Number
PR Web-Site
RTM

USA. G. CD20xCD3 T-cell BiSpecific's products
This section has no products